Small Business Funding for Innovations in Alzheimer’s Disease and Aging

Share on Social Media

The National Institute on Aging (NIA) offers early-stage funding opportunities to small businesses and researchers looking to commercialize innovative treatments or technologies to help people enjoy healthier lives as they age. The NIA Small Business Program is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2022
Current Funding Opportunities

All applicants should consider submitting through the Omnibus Solicitation, which covers a broad range of NIA research topics and investigator-initiated ideas. For small businesses and research organizations working on solutions for Alzheimer’s disease (AD) and AD-related dementias (ADRD), NIA has targeted solicitations for SBIR and STTR that allow for higher budget limits of up to $500,000 for Phase I and $2.5 million for Phase II. These opportunities are part of NIA’s unprecedented research and development budget to develop AD/ADRD interventions and therapeutics. 

The following opportunities are currently open:2021 NIH SBIR Omnibus Solicitation – Clinical Trial Required SBIR (PA-21-260)STTR (PA-21-261)2021 NIH SBIR Omnibus Solicitation – Clinical Trial Not AllowedSBIR (PA-21-259)STTR (PA-21-262)Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD)SBIR (PAS-19-316)STTR (PAS-19-317)Commercialization Readiness Pilot (CRP) Program: SBIR & STTR PA-20-128 (SB1, Technical Assistance) — Clinical Trial Not AllowedSBIR & STTR PA-20-129 (SB1, Technical Assistance, and Late Stage Development) — Clinical Trial Not AllowedSBIR & STTR PA-20-130 (SB1, Technical Assistance, and Late Stage Development) — Clinical Trial Required For a list of NIA SBIR and STTR funding opportunities, deadlines, and budget limits, visit the NIA Small Business Program funding page. 

Latest News

Confluence, convergence on the RI innovation highway

Confluence, convergence on the RI innovation highway MedMates to host the first annual Life Sciences Expo, showcasing the talent and technology here in Rhode Island – as well as some of the gaps Photo by Richard Asinof David Goldsmith, the president of MedMates,...

MedMates to Host Life Sciences EXPO 2017

Posted April 12, 2017 by Sarah Larrow on SVM Public Relations and Marketing Communications Leading-Edge Companies in Biotechnology, Pharmaceuticals, Medical Devices, and Diagnostics to Present at Life Sciences Gathering Providence, R.I., April 12, 2017 – MedMates,...

MedMates Names Carol Malysz as Executive Director

MedMates Names Carol Malysz as Executive Director

Brings Significant Experience in Economic Development and Entrepreneurship to RI’s Life Sciences Technology Network Group Providence, RI – January 10, 2017 MedMates, Rhode Island’s life sciences technology network group, announced today the appointment of Carol Malysz...

Biotech Industry News